Registration Options

Activity Dates: 12/19/2019 - 12/19/2022

Target Audience

This activity is designed to meet the educational needs of pharmacists and other health care professionals who are interested in or managing the medication of patients with OUD.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Complete the pre-test before starting the activity. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Participants in this course must complete an examination and achieve a score of 70% or greater. Up to two exam attempts are provided to each participant. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Describe screening tools specifically developed to evaluate opioid use disorder (OUD) in pregnant and/or lactating people.
  2. Discuss barriers to treatment engagement.
  3. Summarize current controversies in the treatment of pregnant people with medications for opioid use disorder (MOUD).
  4. Evaluate for the risk and prevention of neonatal abstinence syndrome (NAS).
  5. Describe the presenting symptoms of NAS and commonly used assessment tools.
  6. Discuss pharmacologic and non-pharmacologic treatment options for NAS.
  7. Describe the role of breastfeeding in the treatment of NAS or in the postpartum person on pharmacotherapy for OUD. 

Continuing Education Credit and Disclosures

Activity Dates: 12/19/2019 - 12/19/2022
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-19-077-H08-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Grant Support

This activity is supported by an educational grant from Alkermes, Inc.